Globus Medical, Inc.

NYSE:GMED

Medical - Devices

Healthcare
$70.53 -2.71%

-$2.10 today

Market cap
$9.34B
Beta
0.95
P/E (TTM)
17.4
EPS (TTM)
$4.33
52W Low $51.79High $101.40

Volume 1.43M

Average 1.45M

GMED Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Globus Medical, Inc.NYSE: GMED

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) growth accelerates

Q2 FY2026 weighted avg shares (diluted) of 138.19M shares rose 1.2% year over year, ahead of the -0.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +10.2% a year.

Context

  • Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +1.2% holds above the trailing-twelve-month pace of -0.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
138.19M+0.0% QoQ
Last fiscal yearDec 2025
137.22M-0.5% YoY
LTMJun 2026
137.25M-0.9% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.2%——
1 year-0.5%——
3-year CAGR+10.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
137.22M USD
Year-over-year change
-0.5%
4-year CAGR
+7.3%

Weighted Avg Shares (Diluted) vs competitors

How GMED compares with its peers on the latest reported figures

  • GMED's LTM Jun 2026 weighted avg shares (diluted) of 137.25M shares is the 6th highest of the 10 companies compared; the peer median is 149.52M shares.
  • Its year-over-year change of -0.9% is the 9th highest of 10, against a peer median of +3.4%.
  • Over three fiscal years its annual growth of +10.2% compares with a peer median of +3.9%.
GMED Competitors Peer median
Weighted Avg Shares (Diluted) for GMED and competitors
Company Period LTM YoY 3-year CAGR
SNNSmith & Nephew plcFY2025436.47M -0.4%-0.1%
SYKStryker CorporationLTM Jun 2026386.43M +0.1%+0.0%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026196.38M -1.9%-1.9%
ATECAlphatec Holdings, Inc.LTM Mar 2026151.36M +5.1%+13.2%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026149.52M +9.2%+16.8%
GMEDGlobus Medical, Inc.LTM Jun 2026137.25M -0.9%+10.2%
BVSBioventus Inc.LTM Mar 202669.07M +6.0%+3.9%
SIBNSI-BONE, Inc.LTM Mar 202643.36M +3.6%+8.4%
OFIXOrthofix Medical Inc.LTM Mar 202639.93M +3.4%+25.7%
KIDSOrthoPediatrics Corp.LTM Mar 202623.51M +1.4%+3.8%
Peer median (excluding GMED) 149.52M+3.4%+3.9%

Competitors are the stored peer set for GMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue958.1M1.02B1.57B2.52B2.94B
Cost of Revenue239.22M263.73M548.17M1.04B957.8M
Gross Profit718.88M759.12M1.02B1.48B1.98B
Gross Margin75.0%74.2%65.1%58.9%67.4%
Research & Development97.35M73.02M124.01M163.75M185M
Selling, General & Admin408.15M432.12M643.41M981.05M1.32B
Operating Expenses546.93M531.17M887.16M1.32B1.5B
Depreciation & Amortization69.87M68.25M144.73M254.02M276.84M
EBITDA264.73M304.5M346.58M473.73M886.74M
EBITDA Margin27.6%29.8%22.1%18.8%30.2%
Operating Income171.95M227.95M133.14M165.99M479.8M
Operating Margin17.9%22.3%8.5%6.6%16.3%
Interest Income9.3M14.23M20.13M07.14M
Interest Expense0004.19M0
Other Income / Expenses8.45M15.07M32.25M(45.27M)130.1M
Income Before Tax180.41M243.02M165.39M120.72M609.9M
Pre-Tax Margin18.8%23.8%10.5%4.8%20.8%
Income Tax Expense31.22M52.85M42.52M17.74M72M
Net Income149.19M190.17M122.87M102.98M537.9M
Net Margin15.6%18.6%7.8%4.1%18.3%
EPS (Basic)1.481.891.090.763.98
EPS (Diluted)1.441.851.070.753.92
Weighted Avg Shares100.73M100.47M113.09M135.73M135.15M
Weighted Avg Shares (Diluted)103.62M102.64M114.63M137.86M137.22M

Globus Medical, Inc.

NYSE:GMED

Intrinsic Alpha fair value

Locked

Current Price

$70.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.